Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropean Assets Trust Regulatory News (EAT)

Share Price Information for European Assets Trust (EAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 86.80
Bid: 86.20
Ask: 87.80
Change: -0.40 (-0.46%)
Spread: 1.60 (1.856%)
Open: 86.80
High: 87.40
Low: 86.60
Prev. Close: 87.20
EAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results and Quarterly Dividend

29 Mar 2023 07:00

RNS Number : 5395U
European Assets Trust PLC
29 March 2023
 

EUROPEAN ASSETS TRUST PLC

Audited Statement of Results for the year ended 31 December 2022

 

LEI: 213800N61H8P3Z4I8726

 

29 March 2023

 

 

European Assets Trust PLC ("EAT" / "the Company") today announces its results for the year ended 31 December 2022.

 

Financial Highlights

 

· The Sterling Net Asset Value per share total return was -28.2% for the year ended 31 December 2022. This compares to -17.7% for the benchmark, EMIX Smaller European Companies (ex UK) Index.

 

· The Sterling Share Price total return was -28.4% for the year ended 31 December 2022.

 

· A dividend of 5.80 pence per share has been declared for 2023 (2022: 8.80 pence per share). This is equivalent to 6% of the closing Net Asset Value per share on 31 December 2022. The 2023 dividend will be paid in four equal instalments. The first interim dividend of 1.45 pence per share was paid in January 2023 with further dividends payable in April, July, and October.

 

"Europe's valuation metrics continue to look more attractive both in relative and absolute terms. In a very volatile environment there is the risk that any pronouncement one day may look imprudent the next. So, while recognising that risk, we still look forward with a degree of tentative optimism."

 

Jack Perry CBE

Chairman

 

 

Chairman's Statement

 

Fellow Shareholders

European Assets Trust PLC ("the Company") recorded a Sterling Net Asset Value ("NAV") total return for the year ended 31 December 2022 of -28.2% (2021: 16.3%). This compares to the total return of its benchmark, the EMIX Smaller European Companies (ex UK) Index, which fell -17.7% (2021: 14.9%) during the same period. With the discount widening from 4.4% as at 31 December 2021 to 5.1% at the year-end, the Sterling share price total return for the year was -28.4% (2021: 23.2%).

 

The year was clearly very challenging. Almost all asset classes, with the exception of commodities, registered large losses. Global themes of rising inflation, central bank tightening and recession concerns dominated for much of the year. In addition, Europe had to contend with a war on its doorstep exacerbating the already difficult challenges that policy makers faced with rising prices, declining personal incomes and potential gas shortages in the region. Thankfully the worst fears of gas rationing hitting European industrial production were not realised as we entered a mild winter with full gas storage leading to lower prices and better economic data than expected. This helped the year end on a much more positive note with Europe leading global markets higher, perhaps a timely reminder that for long term investors the most challenging periods can lead to the best opportunities.

 

So while there are plenty of mitigating economic factors, the Company's poor relative performance in 2022 is clearly very disappointing. The principal reason for this underperformance was the dramatic rotation out of quality, growth stocks, into value areas. This created an unusual market where normally stable and defensive areas, such as healthcare, led the market down, while traditionally more volatile and economically sensitive sectors, such as commodities significantly outperformed. Given our quality, growth philosophy, this headwind was too much to overcome. We also were hit by having stock specific exposure to an under-pressure consumer and some 'COVID-19 beneficiaries' that suffered from a normalisation of demand. A more detailed discussion of performance attribution can be found in the Investment Managers Review.

 

Dividend

The level of dividend paid each year is determined in accordance with the Company's distribution policy. The Company has stated that, barring unforeseen circumstances, it will pay an annual dividend equivalent to six per cent of its NAV at the end of the preceding year. As the net asset value per share of the Company has decreased since 31 December 2021, the dividend has also decreased from 8.80 pence per share in 2022 to 5.80 pence per share in 2023.

 

While this is unwelcome, it is worth highlighting that the Company's distribution policy offers Shareholders the opportunity of both growth and a high yield from an asset class that comprises some of Europe's most dynamic companies that have significant long-term potential.

 

This 2023 dividend of 5.80 pence per share is payable in four equal instalments of 1.45 pence on 31 January, 28 April, 31 July and 31 October 2023.

 

A dividend of 1.45 pence per share will be paid on 28 April 2023 to Shareholders on the register on 11 April 2023 with ex-dividend date of 6 April 2023.

 

Ownership of the Manager

On 8 November 2021, BMO sold its asset management business in Europe, the Middle East and Africa, ("BMO GAM EMEA") to Columbia Threadneedle Investments. Since November 2021, Columbia Threadneedle Investments has been working to integrate both organisations, focused on delivering the best possible outcomes for all clients. The combined business has more than 2,500 staff, including over 650 investment professionals based in North America, Europe and Asia. At 31 December 2022 it managed £485 billion of client assets.

 

On 4 July 2022, the entire BMO GAM EMEA business was rebranded as Columbia Threadneedle Investments. As part of this process, the Company's appointed Investment Manager, BMO Investment Business Limited, was renamed Columbia Threadneedle Investment Business Limited.

 

Throughout this process, the Board has sought and received confirmation from senior management at Columbia Threadneedle Investments of the importance of maintaining stability and continuity of the teams which presently support your Company. The Board welcomes these assurances and will keep Shareholders informed of developments as this new relationship evolves.

 

Responsible Investment

As longstanding Shareholders will know, consideration of Environmental, Social and Governance ("ESG") issues have long been an important part of the investment process. Following the acquisition of BMO GAM EMEA your Manager has one of the largest and longest established teams dedicated to ESG.

 

There is a detailed report on pages 24 to 27 of the Annual Report which explains the Manager's ESG policies, how these are implemented in the management of the portfolio and its engagement with our investee companies.

 

Directorate Change

European Assets Trust PLC ("EAT PLC") was incorporated on 12 November 2018. It should though be remembered that EAT PLC is the UK domiciled successor of the Company's Dutch predecessor, European Assets Trust NV ("EAT NV") which was dissolved on 16 March 2019. All of the directors of the Supervisory Board of EAT NV were appointed to the Board of EAT PLC on the date of its incorporation. Although EAT PLC and EAT NV were separate legal entities, for governance purposes, the Board regards the date of first appointment to the Supervisory Board of EAT NV as the date of appointment to the continuing business.

 

As part of the Board's succession plan and in accordance with corporate governance best practice, it is anticipated that Julia Bond, the Company's Senior Independent Director, will retire on 31 January 2024. Julia was appointed as a Director of the Supervisory Board of the Company's Dutch predecessor, European Assets Trust NV, in April 2014 and upon retirement will have served nine years between both entities. The Company has benefited immensely from Julia's wide ranging financial and market experience. On behalf of the Board and Shareholders of the Company I thank Julia for her diligence and wise counsel throughout her period of appointment. In advance of Julia's retirement, the Board will recruit a new Director.

 

I was also appointed to the Supervisory Board of the Company's predecessor in April 2014 and became its Chairman with effect from April 2015. In accordance with corporate governance best practice, and to allow a handover period, I announce my intention to retire from the Board at the conclusion of the Company's 2024 Annual General Meeting.

 

Upon my retirement, Stuart Paterson, who was appointed to the Board in July 2019 will become Chairman. Stuart has extensive sector experience as a technology investor with over 25 years of equity investing in European private companies. Stuart has also been an exceptionally diligent and effective Chair of the Audit and Risk Committee. I know that he will continue to serve the Company well.

 

As a further part of this plan, a search company was commissioned to find a new Director for the Board. Following a thorough selection process, Kevin Troup will be appointed to the Board and its committees with effect from 19 May 2023.

 

Kevin is a qualified Chartered Accountant. He has worked in the fund management industry since 1995 with senior investment roles at Scottish Life, Martin Currie and Standard Life Investments. He is now a non-executive director at Baring Fund Managers Limited, TPI Fund Managers Limited and at Baillie Gifford Shin Nippon PLC. He is also a charity Trustee at The Robertson Trust.

 

Following my retirement and Stuart Paterson's assumption of the Chairmanship, Kevin Troup will be appointed Chair of the Company's Audit and Risk Committee.

 

Benchmark

The Company's stated investment policy allows the Manager to invest in small and medium-sized European companies (excluding the UK) which have a market capitalisation below that of the largest company in the EMIX Smaller European Companies (ex UK) Index.

 

IHS Market Benchmark Administration has announced its intention to cease calculation of its EMIX indices with effect from 31 July 2023. The current benchmark of the Company, the EMIX Smaller European Companies (ex UK) Index (Net Return) will therefore be discontinued.

 

The Board, together with its advisers have carefully considered alternative benchmarks to replace the EMIX Smaller European Companies (ex UK) Index and have concluded that the MSCI Europe Ex UK SMID Cap Index, on a net return basis, represents the most appropriate choice, noting, that this index has the greatest overlap of those indices considered with the current portfolio, as well as a similar number of constituents to the current benchmark.

 

The MSCI Europe Ex UK SMID Cap Index, which is composed of European small and mid-cap companies, does have a broader range of market capitalisation within its constituents which is relevant to the upper size limit contained in the investment policy of the Company. The adoption of the MSCI Europe Ex UK SMID Cap Index should therefore be treated as a material change to the Company's investment policy. However, the Manager has confirmed that the selection of the new benchmark does not imply that there will be any change to the existing selection process for investments. 

 

The Board is therefore seeking Shareholder approval for the material change to the investment policy that this new benchmark represents at the Annual General Meeting to be held on 18 May 2023 prior to its adoption with effect from 1 June 2023.

 

Annual General Meeting

The Annual General Meeting ("AGM") will be held at 3.00 pm on 18 May 2023 at the offices of Columbia Threadneedle Investments, Exchange House, Primrose Street, London EC2A 2NY. This will be followed by a presentation by the Investment Manager on the Company and its investment portfolio.

 

For Shareholders who are unable to attend the meeting, any questions they may have regarding the resolutions proposed at the AGM or the performance of the Company can be directed to a dedicated email account, eatagm@columbiathreadneedle.com, by Thursday 11 May 2023. The Board will endeavour to ensure that questions received by such date will be addressed at the meeting. The meeting will be recorded and will be available to view on the Company's website, www.europeanassets.co.uk shortly thereafter. All Shareholders that cannot attend in person are encouraged to complete and submit their Form of Proxy or Form of Direction in advance of the meeting to ensure that their votes will count.

 

Outlook

After a strong start to the year, markets have weakened substantially following the failure of Silicon Valley Bank, other smaller regional banks in the US, and the sell-off of Credit Suisse in Europe. Although investors have been encouraged by the recent bail out of Credit Suisse by UBS and the Swiss authorities, there is clear concern over the risk of contagion to the rest of the financial system and of a renewed financial crisis. While it is too early to draw conclusions we believe that regulators and central banks have reacted quickly and with substance. This combined with more stringent regulation, particularly in Europe, since the global financial crisis provides further support. We do hold banks in the portfolio but these are conservatively run, well capitalised and do not have any funding mismatches. Consequently, we believe they will navigate through this period operationally well. We will however continue to monitor the situation closely.

 

The market's initial assessment of the impact of the banking crisis is that credit conditions are likely to tighten impacting economic growth and this may lower interest rate expectations. This more sober outlook is frustrating given that European markets were leading global markets higher on the combination of attractive valuations and a more optimistic outlook. This view has not yet been completely derailed and Europe's valuation metrics continue to look more attractive both in relative and absolute terms. In a very volatile environment there is the risk that any pronouncement one day may look imprudent the next. So, while recognising that risk, we still look forward with a degree of tentative optimism.

 

Jack Perry CBE

Chairman

28 March 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment Manager's Review

 

Market Backdrop

2022 was a challenging year for almost all asset classes and European smaller companies were no exception, registering significant falls. The initial sell-off, at the beginning of the year, was precipitated by inflation data that caused bond yields to rise and expectations of an earlier and more aggressive interest rate tightening cycle led by the US Federal Reserve. While this theme dominated for most of the year, the bearish sentiment was exacerbated by Russia's invasion of Ukraine in February. Energy and food prices spiked, adding further to inflation concerns, while investors digested what a war on Europe's doorstep would mean for the region's economic activity, with potential gas shortages the principal area of concern. Meanwhile, China's zero COVID-19 policy and regional lockdowns added to global supply chain restrictions that were already under severe pressure, further fuelling rising input costs. In response, central banks became increasingly hawkish, prioritising the fight against inflation over supporting economic activity. Geopolitical risks, rapidly rising interest rates and increasing recessionary expectations therefore dominated markets for most of the year until the fourth quarter brought some much-needed respite. Encouragingly, Europe finished the year particularly strongly, leading global markets higher. While rates kept rising, US and European inflation data came in below expectations, allowing investors to ponder lower peak rates. Economic indicators, whilst still pointing to activity softening, were also better than expected. In Europe this was helped by the dramatic decline in natural gas prices due to the combination of a mild start to winter and full gas storage facilities. Despite a strong year end, however, 2022 was a poor year for investors.

Performance

Our portfolio performed poorly last year, significantly underperforming the index. The main reason was the dramatic rotation out of quality, growth stocks into value areas of the market. This was caused by interest rate rises which have a detrimental impact on the valuation of companies whose value is derived from cash flows that grow over a long time frame. This rotation was exacerbated by the strong moves in commodities, the only major asset class that registered gains last year, driven by a rush towards energy security following the war in Ukraine. Our philosophy and portfolio style are biased towards growth companies, so it is perhaps no surprise that we performed poorly, however, we are clearly disappointed by the scale of our relative underperformance. Within the portfolio, we had built some balance with exposure to rising interest rates, principally through our holdings in financials, but this balance was overwhelmed by the scale of sector rotation.

The performance was also heavily impacted by some stocks that were exposed to a consumer whose disposable incomes were under pressure from rising costs. These stocks were also having to contend with a period of softening demand as they digested the hangover from some unusually strong COVID-19 years. For example, MIPs, who supply technology for principally cycle helmets, and Thule, who sell stylish products for active families and outdoor enthusiasts, both announced disappointing trading updates. Whilst neither of these companies are suffering from excess inventories of their products in the retail channel, nor a demand problem, retailers are struggling with excess inventories of other, low value items in their stores that need to be cleared before they can restock with higher end products from MIPs and Thule. Once this inventory is cleared, which may take some time, we would expect both companies see demand patterns in line with their long-term positive trajectory. Other consumer related stocks that suffered from difficult comparisons with very strong trading in recent years were Fluidra, the swimming pool equipment suppliers, and HelloFresh, the leading meal kit provider. We continue to hold these positions in anticipation of better demand trends later in the year and because we believe in the long-term structural growth opportunities for these businesses.

The technology sector was also an area that struggled from similar themes. Despite delivering good operational performance through the year, our semiconductor stocks ASMI, the equipment provider, and Nordic Semiconductor, the leading Bluetooth company, saw their valuations heavily de-rated through the year as investors sold out of growth companies. Industrials also struggled, and while we were underweight the sector, stock specifics overwhelmed sector allocation. Forbo, the Swiss listed flooring company, and Norma Group, the German listed autosupplier, both delivered poor operational updates that caused us to sell these holdings. Wizz Air, was another poor performer as it faced the twin headwinds of higher fuel costs and a weaker consumer. We cut the position significantly at the outset of the Ukrainian war, mitigating the damage, before adding later in the year. This proved to be a good decision with the shares recovering strongly into this year.

Turning to more positive outcomes, our best contributor to our performance in terms of sector came from healthcare. This was slightly peculiar because the sector, unusually in a down market, was the worst performer, underperforming even consumer discretionary at the index level. Our positive stock selection meant that this was the best contributor though, with Tecan, the Swiss listed diagnostics company, leading the way supported by an upgrade to guidance at their first half results.

The materials sector also yielded some good performance with both our sector allocation and stock selection being good. Of note were our holdings in Verallia, the French glass manufacturer, and SIG, the Swiss listed aseptic packaging supplier, both of which consistently delivered strong operational results. One of our new positions, Hexpol, the supplier of polymer compounds, also performed well due partly to its large exposure to the strong dollar but mainly due to encouraging results.

Finally, in terms of sectors, our traditional financials contributed well. Interest rates, a long-term headwind for the sector have finally turned supportive. Ringkjoebing Landbobank, listed in Denmark, Sparebank, listed in Norway, and Storebrand, the Norwegian life insurance company, all had strong years. Bank of Ireland, a new holding, was, however, the highlight being the best performer as investors began to appreciate the strong economic backdrop that Ireland offers, the cheap valuation, higher interest rates, a consolidated market and improving results.

Other stocks worthy of mention include Lotus Bakeries, the owner of the Biscoff brand, whose consistent profit delivery was appreciated by the markets. Finally, another new addition, Schoeller Bleckmann, performed strongly. Austrian listed, this company is the leading supplier of non-magnetic steel components to the oil and gas industry and, rose after its results outperformed on the back of the scramble towards energy security caused by Russia's invasion of Ukraine.

Portfolio Activity

Portfolio turnover was broadly in line with long-term averages. Trading was driven by a combination of executing our philosophy and process whilst recognising emerging priorities. On the latter, we are aware that energy security is a key geopolitical focus now. Following a decade of underinvestment on the supply side we may be at the start of a new capital cycle in the sector. We have invested in quality companies that are exposed to this; Schoeller Bleckman mentioned above and TGS, the seismic analytics company. We also believe that tight labour markets and re-shoring of industrial production will lead to a greater investment in automation and so have started positions in Kardex, whose equipment optimises and automates logistical workflows, and Engcon, the Swedish listed market leader of tilt rotators that improve the productivity of excavators. The other characteristic of this market cycle is likely to be higher interest rates as core inflation remains high in contrast to the previous decade. We have expressed this view through our holdings in regional banks and life insurance, which was augmented by the decision to add Bank of Ireland early in the year.

We have also been cognisant that market falls usually provide opportunity. While we have not been as active in this regard compared to what we executed during the outset of the COVID-19 pandemic, following our process has meant that we have added some new positions in addition to those mentioned earlier in this commentary. Examples include Viscofan, the market leader in the global synthetic sausage skin oligopoly, Siegfried, which holds a strong position as an outsourced manufacturer of small molecules for pharmaceutical companies, and Vidrala, the Spanish bottling company.

Our sell decisions were driven by a more critical appraisal of operational performance during a period when quality credentials were tested. For example, following disappointing trading updates, we sold, in addition to those mentioned above, holdings in Cancom, the German IT reseller, Marr, the Italian food services business, Simcorp, the asset management software business, and FlatexDegiro, the German listed, low-cost retail brokerage firm.

Outlook

The year had started strongly, with Europe pleasingly leading the way. This has, however, been derailed by the failure of Silicon Valley Bank (SVB) in the US and Credit Suisse in Europe. This has caused a significant sell-off across the market driven by the financial sector. The failure of any financial institution brings back memories of the Global Financial Crisis, however we think, there are reasons to be less concerned this time. Financial regulation in terms of capital requirements and funding, particularly in Europe, are much more robust, whilst central banks and financial regulators have reacted quickly. There will, however, be some significant ramifications from this of which some will not be understood yet. Initially, it is fair to assume that credit conditions will be tighter, adding further to the challenging calculations that central bankers are having to make with regard interest rate rises.

In terms of stock picking the clear lesson from recent events is to avoid companies whose business models have been supported by low rates and are challenged by the dramatic change in interest rate regime that we have seen over the last year. There will be further casualties, but we believe our quality biased approach avoids such exposure. We are, however, looking closely at the opportunities that may present themselves as good businesses potentially get dragged down by recent events. Prior to the sell-off, Europe looked attractively valued both in absolute levels and relative to global markets. This provides an attractive backdrop to stock picking and future long-term returns.

 

Sam Cosh

Lead Investment Manager

28 March 2023

 

 

 

 

Principal Risks and Future Prospects

The principal risks together with their mitigations are set out below. The Board's processes for monitoring them and identifying emerging risks are set out on pages 28 to 29 and in note 22 of the Report & Accounts.

 

Most of the Company's principal risks are market related and no different to those of other investment trusts investing in listed markets. 

 

The global economy continues to suffer considerable disruption due to the effects of the COVID-19 pandemic, inflationary concerns and the war in Ukraine. The Directors have reviewed the risk register for the Company which identifies the risks that the Company is exposed to, the controls in place and the actions being taken to mitigate them. The principal ongoing risks and uncertainties currently faced by the Company, and the controls and actions to mitigate those risks, are described below.

 

In addition a detailed review of the risks of the Company's investment portfolio including market, credit, foreign currency and liquidity is provided in note 22 of the Report & Accounts beginning on page 67. Details of actions taken to reduce the potential impact of these risks is also provided.

 

· Risk description: Poor absolute and/or relative performance

Inappropriate stock selection, asset allocation and gearing levels result in poor NAV and share price performance against benchmark and/or peer group. Failing performance results in reduced demand for the Company's shares and a widening share price discount.

Ø No change in overall risk in year

 

Mitigation: At each Board meeting the Directors monitor performance against benchmark and peer group. The Manager attends each regular board meeting and will discuss the reasons for any over or underperformance.

The Company's broker, Panmure Gordon, will provide market intelligence at each meeting noting underlying demand for the Company's shares.

The Company has received the necessary authority from shareholders to regulate the premium or discount that the Company's shares may trade at by purchasing or issuing shares.

 

· Risk description: Relevance/attractiveness of the investment strategy and policy

An unattractive investment strategy, loss of cost competitiveness and/or a changing investment product environment, including ESG, leads to a fall in demand for the Company's shares resulting in an increasing share price discount.

Ø No change in overall risk in year

 

Mitigation: Investment policy and performance are reviewed by the Board at each meeting. Rigorous individual stock reviews are regularly performed by the Manager and action taken to either hold, accumulate or sell. Cash, borrowing and gearing limits are set and monitored regularly.

 

· Risk description: The Manager

Failure of Investment Manager or loss of senior staff could cause reputational damage and/or place the business in jeopardy. Execution risk arising from the acquisition of BMO GAM EMEA by Columbia Threadneedle.

Ø No change in overall risk in year

 

Mitigation: The Board meets regularly with the management of Columbia Threadneedle Investments and receives an annual Audit Assurance Faculty Report on its procedures. The Manager's appointment can be terminated at six months' notice. Key man risk is limited by the team approach adopted by the Global Smaller team at Columbia Threadneedle Investments.

 

 

 

 

 

 

· Risk description: Regulatory and compliance (including ESG reporting)

To maintain its investment trust status, the Company is required to comply with Section 1158 of the UK Corporation Taxes Act. The Company is also required to comply with UK company law, is subject to the requirements of the AIFMD and the relevant regulations of the London Stock Exchange and the Financial Conduct Authority.

Ø No change in overall risk in year

 

Mitigation: At each Board meeting the Company receives an update from the Secretary on legal, regulatory and accounting developments. The Company is a member of the Association of Investment Companies which provides guidance on regulatory developments. The Company has appointed EY LLP as its tax advisor and Shepherd and Wedderburn as its legal counsel. The Manager has a long established and highly regarded Responsible Investment team which presents to the Board annually.

 

· Risk description: Service provider failure

Errors, fraud or control failures at service providers or loss of data through increasing cyber threats or business continuity failure could damage reputation or investors' interests or result in losses.

Ø No change in overall risk in year

 

Mitigation: The Board receives regular control reports from the Manager covering risk and compliance including oversight of third-party service providers. The Board has access to the Manager's Risk Manager and requires any significant issues directly relevant to the Company to be reported immediately. The Depositary is specifically liable for loss of any of the Company's securities and cash held in custody.

 

· Risk description: Dividend Policy

The Company's high distribution policy becomes unsustainable.

Ø No change in overall risk in year

 

Mitigation: The annual dividend is calculated as six per cent of the closing net asset value of the Company as at 31 December of the preceding year.

As at 31 December 2022 the Distributable reserves of the Company was £296.9 million in comparison to a 2022 dividend cost of £31.7 million.

 

· Risk description: Geopolitical issues and their impact

Macroeconomic and geopolitical risk including the possibility of prolonged recession in the United Kingdom and the impact of the war in Ukraine.

Ø Increase in overall risk in year

 

Mitigation: The Company has a clearly defined and approved strategy. The Board can hold additional board meetings at short notice to discuss the impact of significant changes in the macroeconomic and geo-political environment. The Company maintains a portfolio of diversified stocks.

Forward looking stress tests ranging from moderate to extreme scenarios are provided by the Manager to the Board to support the Viability and Going Concern Statements.

 

Five Year Horizon

 

Through a series of connected stress tests ranging from moderate to extreme scenarios and based on historical information, but forward looking over the five years commencing 1 January 2023, the Board assessed the risks of:

· the liquidity of the Company's portfolio;

· the existence of a borrowing facility;

· the effects of any significant future falls in investment values and income receipts on the ability to repay and re-negotiate borrowings;

· the maintenance of dividend payments and the retention of investors;

· the potential need for more share issuance capacity in the event of unexpected market demand; and

· minimising the discount between the Company's share price and net asset value.

 

The UK Corporate Governance Code requires a board to assess the future prospects for a company, and report on the assessment within the annual report.

 

Based on their assessment, and in the context of the Company's business model, strategy and operational arrangements set out

above, the Board has a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the five year period to March 2028. For this reason, the Board also considers it appropriate to continue adopting the going concern basis in preparing the Report and Accounts. Statement of Directors' Responsibilities in Respect of the Financial Statement

Each of the Directors, whose names and functions are listed on page 30 of the Report & Accounts, confirm that, to the best of their knowledge:

 

· the Company financial statements, prepared in accordance with UK-adopted International Accounting Standards, give a true and fair view of the assets, liabilities, financial position and profit of the Company;

· the Strategic Report includes a fair review of the development and performance of the business and the position of the Company, together with a description of the principal risks and uncertainties that they face; and

· the annual report and financial statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for Shareholders to assess the Company's position and performance, business model and strategy.

 

 

On behalf of the Board

Jack Perry

Chairman

28 March 2023

 

Statement of Comprehensive Income

 

For the year ended

31 December 2022

For the year ended

31 December 2021

 

Revenue

Capital

Total

Revenue

Capital

Total

 

£'000s

£'000s

£'000s

£'000s

£'000s

£'000s

 

 

 

 

(Losses)/gains on investments held at fair value through profit or loss

-

(177,223)

(177,223)

-

102,892

102,892

Foreign exchange (losses)/gains

(25)

(86)

(111)

8

469

477

Income

8,527

-

8,527

8,157

-

8,157

Management fee

(610)

(2,438)

(3,048)

(739)

(2,954)

(3,693)

Other expenses

(958)

(37)

(995)

(995)

(7)

(1,002)

Profit/(loss) before finance costs and taxation

6,934

(179,784)

(172,850)

6,431

100,400

106,831

Finance costs

(51)

(206)

(257)

(50)

(201)

(251)

Profit/(loss) before taxation

6,883

(179,990)

(173,107)

6,381

100,199

106,580

Taxation

(944)

-

(944)

(937)

-

(937)

Profit/(loss) for the year and total comprehensive income

5,939

(179,990)

(174,051)

5,444

100,199

105,643

 

 

 

 

Earnings per share basic and diluted - pence

1.65

(49.99)

(48.34)

1.51

27.83

29.34

 

The total column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with UK-adopted International Accounting Standards. The supplementary revenue return and capital return columns are both prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in the above statement derive from continuing operations.

 

 

 

Statement of Changes in Equity

 

for the year ended

31 December 2022

 

 

 

 

 

 

 

 

 

Share

 

Distributable

 

Capital

 

Revenue

Cumulative

translation

Total

Shareholders'

 

capital

reserve

Reserves

reserve

reserve

funds

 

£'000s

£'000s

£'000s

£'000s

£'000s

£'000s

 

 

 

 

 

 

 

Balance at 31 December 2021

37,506

322,694

188,661

-

(23,426)

525,435

Movements during the year ended

31 December 2022

 

 

 

 

 

 

 

Interim dividends distributed

 

-

(25,749)

-

(5,939)

-

(31,688)

Total comprehensive income

 

-

-

(179,990)

5,939

-

(174,051)

Cumulative translation adjustment

 

-

-

-

-

27,931

27,931

Balance at 31 December 2022

 

37,506

296,945

8,671

-

4,505

347,627

 

 

 

 

for the year ended

31 December 2021

 

 

 

 

 

 

 

 

 

Share

 

Distributable

 

Capital

 

Revenue

Cumulative

translation

Total

Shareholders'

 

capital

reserve

Reserves

reserve

reserve

funds

 

£'000s

£'000s

£'000s

£'000s

£'000s

£'000s

 

 

 

 

 

 

 

Balance at 31 December 2020

37,506

346,054

88,462

-

5,982

478,004

Movements during the year ended

31 December 2021

 

 

 

 

 

 

 

Interim dividends distributed and reinvested

 

-

(23,360)

-

(5,444)

-

(28,804)

Total comprehensive income

 

-

-

100,199

5,444

-

105,643

Cumulative translation adjustment

 

-

-

-

-

(29,408)

(29,408)

Balance at 31 December 2021

 

37,506

322,694

188,661

-

(23,426)

525,435

Statement of Financial Position

 

 

at 31 December

2022

2021

£'000s

£'000s

Non-current assets

 

Investments at fair value through profit or loss

340,717

539,756

Current assets

 

Other receivables

3,247

2,680

Cash and cash equivalents

13,317

8,342

Total current assets

16,564

11,022

Current liabilities

 

Other payables

(782)

(155)

Bank Loan

(8,872)

(25,188)

Total current liabilities

(9,654)

(25,343)

Net current assets/(liabilities)

6,910

(14,321)

Net assets

347,627

525,435

 

 

Capital and reserves

 

Share capital

37,506

37,506

Distributable reserve

296,945

322,694

Capital reserve

8,671

188,661

Revenue reserve

-

-

Cumulative translation reserve

4,505

(23,426)

Total Shareholders' funds

347,627

525,435

 

 

Net asset value per ordinary share - pence

96.54

145.93

 

 

 

 

Statement of Cash Flows

 

for the year ended 31 December

2022

2021

£'000s

£'000s

Cash flows from operating activities before interest and dividends received and interest paid

 

(3,353)

 

(4,660)

Dividends received

6,990

6,842

Interest received

34

-

Interest paid

(257)

(271)

Cash flows from operating activities

3,414

1,911

Investing activities

 

Purchase of investments

(107,060)

(107,481)

Sale of investments

156,430

139,299

Other capital charges

(37)

(7)

Cash flows from investing activities

49,333

31,811

Cash flows before financing activities

52,747

33,722

Financing activities

 

Equity dividends paid

(31,688)

(28,804)

Drawdown of bank loan

-

8,538

Repayment of bank loan

(17,173)

(8,500)

Cash flows from financing activities

(48,861)

(28,766)

Net movement in cash and cash equivalents

3,886

4,956

Cash and cash equivalents at the beginning of the year

8,342

2,950

Effect of movement in foreign exchange

(111)

477

Translation adjustment

1,200

(41)

Cash and cash equivalents at the end of the year

13,317

8,342

 

 

Represented by:

 

Cash at bank

9

13

Short term deposits

13,308

8,329

13,317

8,342

 

 

 

 

 

 

 

Notes

 

1 Translation

The functional currency of the Company is the euro and presentational currency is pound sterling.

 

2 Earnings per ordinary share

Revenue return

The revenue return per share of 1.65p (2021: 1.51p) is based on the revenue return attributable to Shareholders of £5,939,000 profit (2021: £5,444,000 profit).

 

Capital return

The capital return per share of -49.99p (2021: 27.83p) is based on the capital return attributable to Shareholders of £179,990,000 loss (2021: £100,199,000 profit).

 

Total return

The total return per share of -48.34p (2021: 29.34p) is based on the total return attributable to Shareholders of £174,051,000 loss (2021: £105,643,000 profit).

 

Weighted average ordinary shares in issue

The returns per share are based on a weighted average of 360,069,279 (2021: 360,069,279) ordinary shares in issue during the year.

 

3 Dividends

The Board has declared a total dividend for 2023 of 5.80 (2022: 8.80) pence per share in accordance with its aim of paying at a rate of six per cent of the closing Net Asset Value of the preceding year.

 

4 Financial risk management

The Company is an investment company, listed on the London Stock Exchange, and conducts its affairs so as to qualify in the United Kingdom ("UK") as an investment trust under the provisions of section 1158 of the CTA. In so qualifying, the Company is exempted in the UK from corporation tax on capital gains on its portfolio of investments.

 

The Company's investment objective is to achieve long-term growth of capital through investment in quoted small and medium sized companies in Europe, excluding the United Kingdom. In pursuing this objective, the Company is exposed to financial risks which could result in a reduction of either or both of the value of the net assets and the profits available for distribution by way of dividend. These financial risks are principally related to the market (currency movements, interest rate changes and security price movements), liquidity and credit. The Board, together with the Manager, is responsible for the Company's risk management.

 

The full details of financial risks are contained in note 22 of the Report and Accounts.

 

5 Annual general meeting

The 2023 AGM will be held on 18 May 2023 at 3.00pm at Exchange House, Primrose Street, London, EC2A 2NY. The Notice of the AGM is set out on pages 73 to 77 of the annual report.

 

6 Report and accounts

The report and accounts for the year ended 31 December 2022 will be posted to Shareholders and made available on the website www.europeanassets.co.uk shortly. Copies may also be obtained by mailing the Company's registered office, Exchange House, Primrose Street, London EC2A 2NY.

 

By order of the Board

Columbia Threadneedle Investment Business Limited, Secretary

28 March 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR GZGZFLRNGFZM
Date   Source Headline
2nd May 20247:00 amRNSLead Manager Change and Management Fee Amendment
1st May 20243:43 pmRNSNet Asset Value(s)
1st May 20249:35 amRNSTotal Voting Rights
30th Apr 202412:47 pmRNSNet Asset Value(s)
29th Apr 202412:42 pmRNSNet Asset Value(s)
26th Apr 202412:30 pmRNSNet Asset Value(s)
25th Apr 202412:50 pmRNSNet Asset Value(s)
24th Apr 202412:43 pmRNSNet Asset Value(s)
23rd Apr 20241:07 pmRNSNet Asset Value(s)
22nd Apr 20241:01 pmRNSNet Asset Value(s)
19th Apr 202412:42 pmRNSNet Asset Value(s)
18th Apr 202412:24 pmRNSNet Asset Value(s)
17th Apr 202412:56 pmRNSNet Asset Value(s)
17th Apr 202410:45 amRNSPortfolio Update
16th Apr 20241:09 pmRNSNet Asset Value(s)
15th Apr 202412:50 pmRNSNet Asset Value(s)
12th Apr 20241:46 pmRNSNet Asset Value(s)
11th Apr 20241:13 pmRNSNet Asset Value(s)
10th Apr 202412:42 pmRNSNet Asset Value(s)
9th Apr 202412:54 pmRNSNet Asset Value(s)
8th Apr 20241:14 pmRNSNet Asset Value(s)
5th Apr 20241:06 pmRNSNet Asset Value(s)
4th Apr 20241:02 pmRNSNet Asset Value(s)
3rd Apr 202412:46 pmRNSNet Asset Value(s)
2nd Apr 20241:49 pmRNSNet Asset Value(s)
2nd Apr 202410:37 amRNSTotal Voting Rights
28th Mar 202412:52 pmRNSNet Asset Value(s)
27th Mar 20241:15 pmRNSNet Asset Value(s)
26th Mar 20241:11 pmRNSNet Asset Value(s)
25th Mar 202412:57 pmRNSNet Asset Value(s)
22nd Mar 202412:49 pmRNSNet Asset Value(s)
22nd Mar 20249:49 amRNSPortfolio Update
22nd Mar 20249:46 amRNSDirector/PDMR Shareholding
21st Mar 20241:29 pmRNSNet Asset Value(s)
20th Mar 202412:46 pmRNSNet Asset Value(s)
19th Mar 20241:01 pmRNSNet Asset Value(s)
18th Mar 202412:58 pmRNSNet Asset Value(s)
15th Mar 202412:41 pmRNSNet Asset Value(s)
14th Mar 20241:09 pmRNSNet Asset Value(s)
13th Mar 20241:01 pmRNSNet Asset Value(s)
12th Mar 202412:50 pmRNSNet Asset Value(s)
11th Mar 20241:37 pmRNSNet Asset Value(s)
8th Mar 20241:26 pmRNSNet Asset Value(s)
7th Mar 20241:25 pmRNSNet Asset Value(s)
6th Mar 202412:59 pmRNSNet Asset Value(s)
5th Mar 20242:42 pmRNSNet Asset Value(s)
4th Mar 202412:41 pmRNSNet Asset Value(s)
1st Mar 202412:30 pmRNSNet Asset Value(s)
1st Mar 202411:20 amRNSMajor Shareholder Notification
1st Mar 20249:19 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.